Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience.

Clinical journal of the American Society of Nephrology : CJASN

Volumn 1, Issue 4, 2006, Pages 844-852

  Vo, Ashley A ^a   Cam, Vinh ^a   Toyoda, Mieko ^a   Puliyanda, Dechu P ^a   Lukovsky, Marina ^a   Bunnapradist, Suphamai ^a   Peng, Alice ^a   Yang, Kai ^a   Jordan, Stanley C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOLOGIC FACTOR;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CHILD; FEMALE; HEART INFARCTION; HUMAN; INFANT; MALE; MIDDLE AGED; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SAFETY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; SAFETY;

EID: 33847416558     PISSN: None     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01701105     Document Type: Article

References (0)